| Date | Time | Source | Headline | Symbol | Company |
| 02/14/2011 | 6:19PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/10/2011 | 8:00AM | Marketwired | AVI BioPharma to Present Company Overview at the 13th Annual BIO CEO & Investor Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/25/2011 | 12:02PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/11/2011 | 4:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/10/2011 | 3:41PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/07/2011 | 8:00AM | Marketwired | AVI Biopharma Names Effie Toshav Senior Vice President and General Counsel | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/06/2011 | 8:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/06/2011 | 8:00AM | Marketwired | AVI BioPharma to Present at the 29th Annual JPMorgan Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/05/2011 | 8:00AM | Marketwired | AVI BioPharma and Leading Researchers at Karolinska Institutet Form Collaboration to Identify RNA-Based Therapeutic Candidates f | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/03/2011 | 8:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/27/2010 | 7:30AM | Marketwired | AVI BioPharma Provides Update on Duchenne Muscular Dystrophy Program | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2010 | 8:33AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/13/2010 | 7:00AM | Marketwired | AVI BioPharma Names Chris Garabedian Chief Executive Officer | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/03/2010 | 2:55PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/17/2010 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/15/2010 | 10:00AM | Marketwired | AVI BioPharma to Present at Maxim Group Growth Conference 2010 | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/12/2010 | 8:05PM | GlobeNewswire Inc. | Semi-Annual Changes to the NASDAQ Biotechnology Index | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/11/2010 | 2:00PM | Marketwired | AVI BioPharma to Present Data for RNA-Based Influenza Drug Candidates at 2010 Chemical and Biological Defense Science and Techno | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2010 | 4:32PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2010 | 4:28PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2010 | 4:00PM | Marketwired | AVI BioPharma Announces Third Quarter 2010 Financial Results | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/05/2010 | 2:13PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/03/2010 | 8:00AM | Marketwired | AVI BioPharma Awarded $1.2 Million in U.S. Government Grants for Five Qualifying Therapeutic Development Projects Involving RNA- | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/02/2010 | 1:00PM | Marketwired | AVI BioPharma Announces Third Quarter 2010 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/27/2010 | 8:30AM | Marketwired | AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/20/2010 | 8:30AM | Marketwired | AVI BioPharma to Present Data on RNA-Based Duchenne Muscular Dystrophy and Influenza Drug Candidates at 6th Annual Meeting of th | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/20/2010 | 8:30AM | Marketwired | Data From AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented at 48th Annual Meeting of Infectious Dis | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/19/2010 | 8:30AM | Marketwired | AVI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/18/2010 | 8:06AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/15/2010 | 8:00AM | Marketwired | AVI BioPharma's Investigational Drug Candidate AVI-4658 Demonstrates Broadly Favorable Profile of Safety and Tolerability, New D | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |